Literature DB >> 27046449

Loss of interactions between p53 and survivin gene in mesenchymal stem cells after spontaneous transformation in vitro.

Liu He1, Fangyu Zhao2, Yong Zheng3, Yu Wan4, Jian Song5.   

Abstract

Mesenchymal stem cells (MSC) from various animals undergo a spontaneous transformation in long-term culture. The transformed MSCs are highly tumorigenic and are likely to be the tumor-initiating cells of sarcoma. To explain why the transformed MSCs become tumorigenic, the present study investigated the characteristics of rat MSCs before and after spontaneous transformation. It was shown that although the transformed MSCs maintained typical surface markers of MSC, they exhibited some cancer stem cell-like characteristics such as loss of contact inhibition and multi-potency to mesenchymal lineages, and acquirement of ability of anchorage-independent growth. The expression of a key senescence regulator p16 almost disappeared, but the other one, p53 abnormally increased in the transformed MSCs. ChIP assay demonstrated that a normal negative regulation of p53 on survivin gene disappeared in the transformed cells due to a lack of p53 binding to the promoter of survivin gene. DNA sequencing revealed that the p53 gene in transformed MSCs was not a wild-type, but a 942C>T mutant with the mutation located in the sequence coding p53 protein's DNA-binding domain. These findings indicate that the transformed MSCs express high levels of a p53 mutant that loses the ability to bind survivin gene, leading to an abnormally upregulated expression of survivin, which is a key reason for the cell's unlimited proliferation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell transformation; Mesenchymal stem cells; Survivin; p53

Mesh:

Substances:

Year:  2016        PMID: 27046449     DOI: 10.1016/j.biocel.2016.03.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  The role and mechanism of miR-374 regulating the malignant transformation of mesenchymal stem cells.

Authors:  Zixuan Sun; Jingyan Chen; Jiao Zhang; Runbi Ji; Wenrong Xu; Xu Zhang; Hui Qian
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

Review 2.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

Review 3.  Mesenchymal stem cell-derived extracellular vesicles in the failing heart: past, present, and future.

Authors:  Catherine Karbasiafshar; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-16       Impact factor: 4.733

Review 4.  Double-edged sword of mesenchymal stem cells: Cancer-promoting versus therapeutic potential.

Authors:  Hwa-Yong Lee; In-Sun Hong
Journal:  Cancer Sci       Date:  2017-08-29       Impact factor: 6.716

5.  Differentiation Potential and Tumorigenic Risk of Rat Bone Marrow Stem Cells Are Affected By Long-Term In Vitro Expansion

Authors:  Erdal Karaöz; Filiz Tepeköy
Journal:  Turk J Haematol       Date:  2019-07-09       Impact factor: 1.831

6.  Rogue stem cell clinics.

Authors:  Iain R Murray; Jorge Chahla; Rachel M Frank; Nicolas S Piuzzi; Bert R Mandelbaum; Jason L Dragoo
Journal:  Bone Joint J       Date:  2020-02       Impact factor: 5.082

Review 7.  Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI.

Authors:  Rami Ahmad Shahror; Chung-Che Wu; Yung-Hsiao Chiang; Kai-Yun Chen
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

Review 8.  An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells.

Authors:  Dinh-Toi Chu; Thuy Nguyen Thi Phuong; Nguyen Le Bao Tien; Dang Khoa Tran; Vo Van Thanh; Thuy Luu Quang; Dang Tien Truong; Van Huy Pham; Vo Truong Nhu Ngoc; Thien Chu-Dinh; Kushi Kushekhar
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.